BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30078474)

  • 1. Synthesis, characterization and nociceptive screening of new VV-hemorphin-5 analogues.
    Todorov P; Peneva P; Pechlivanova D; Georgieva S; Dzhambazova E
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3073-3079. PubMed ID: 30078474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential anticonvulsant activity of novel VV-hemorphin-7 analogues containing unnatural amino acids: synthesis and characterization.
    Todorov P; Peneva P; Tchekalarova J; Georgieva S
    Amino Acids; 2020 Apr; 52(4):567-585. PubMed ID: 32206933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant evaluation and docking analysis of VV-Hemorphin-5 analogues.
    Todorov P; Rangelov M; Peneva P; Todorova N; Tchekalarova J
    Drug Dev Res; 2019 Jun; 80(4):425-437. PubMed ID: 30681179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive Effects of VV-Hemorphin-5 Peptide Analogues Containing Amino phosphonate Moiety in Mouse Formalin Model of Pain.
    Assenov B; Pechlivanova D; Dzhambazova E; Peneva P; Todorov P
    Protein Pept Lett; 2021; 28(4):442-449. PubMed ID: 32798365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization, and biological study of new synthetic opioid hemorphin-4 peptides containing sterically restricted nonnatural amino acids.
    Todorov P; Georgieva S; Trapella C; Chakarov K; Tchekalarova J; Pechlivanova D; Cheshmedzhieva D; Fantinati A; Illuminati D
    Arch Pharm (Weinheim); 2024 Jul; 357(7):e2400052. PubMed ID: 38578075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization and anticonvulsant activity of new series of N-modified analogues of VV-hemorphin-5 with aminophosphonate moiety.
    Todorov P; Peneva P; Tchekalarova J; Rangelov M; Georgieva S; Todorova N
    Amino Acids; 2019 Nov; 51(10-12):1527-1545. PubMed ID: 31576456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship study on new hemorphin-4 analogues containing steric restricted amino acids moiety for evaluation of their anticonvulsant activity.
    Todorov P; Peneva P; Tchekalarova J; Georgieva S; Rangelov M; Todorova N
    Amino Acids; 2020 Oct; 52(10):1375-1390. PubMed ID: 33011823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antinociceptive activity of peptides related to interleukin-1 beta 193-195 Lys-Pro-Thr.
    Caliendo G; Greco G; Grieco P; Perissutti E; Santagada V; Ialenti A; Maffia P; Albrizio S; Santini A
    Biopolymers; 1996; 40(5):479-84. PubMed ID: 9062070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive activity of peptides related to interleukin-1 beta-(193-195), Lys-Pro-Thr.
    Oluyomi AO; Poole S; Smith TW; Hart SL
    Eur J Pharmacol; 1994 Jun; 258(1-2):131-8. PubMed ID: 7925591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valorphins alter physicochemical characteristics of phosphatidylcholine membranes: Datasets on lipid packing, bending rigidity, specific electrical capacitance, dipole potential, vesicle size.
    Vitkova V; Staneva G; Hazarosova R; Georgieva SI; Valkova I; Antonova K; Todorov P
    Data Brief; 2022 Dec; 45():108716. PubMed ID: 36426033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the structure-activity relationship in a series of new LVV- and VV-hemorphin-7 analogues designed as potential anticonvulsant agents.
    Todorov P; Georgieva S; Peneva P; Tchekalarova J
    Amino Acids; 2022 Feb; 54(2):261-275. PubMed ID: 34978007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioligand binding properties of VV-hemorphin 7, an atypical opioid peptide.
    Szikra J; Benyhe S; Orosz G; Darula Z; Piot JM; Fruitier I; Monory K; Hanoune J; Borsodi A
    Biochem Biophys Res Commun; 2001 Mar; 281(3):670-7. PubMed ID: 11237710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization and evaluation of anti-hyperalgesia, anticonvulsant and antioxidant activity of novel VV-hemorphin-5 analogs.
    Todorov P; Georgieva S; Tchekalarova J; Peneva P; Mateeva P; Assenov B; Dzhambazova E; Pechlivanova D
    Arch Pharm (Weinheim); 2023 Oct; 356(10):e2300267. PubMed ID: 37532631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of new VV-hemorphin-5 analogues with cell membrane models.
    Vitkova V; Staneva G; Hazarosova R; Georgieva SI; Valkova I; Antonova K; Todorov P
    Colloids Surf B Biointerfaces; 2022 Dec; 220():112896. PubMed ID: 36270140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid and peptide prodrugs of diphenylpropanones positive allosteric modulators of α7 nicotinic receptors with analgesic activity.
    Balsera B; Mulet J; Sala S; Sala F; de la Torre-Martínez R; González-Rodríguez S; Plata A; Naesens L; Fernández-Carvajal A; Ferrer-Montiel A; Criado M; Pérez de Vega MJ; González-Muñiz R
    Eur J Med Chem; 2018 Jan; 143():157-165. PubMed ID: 29174812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization and anticonvulsant activity of new azobenzene-containing VV-hemorphin-5 bio photoswitch.
    Todorov PT; Peneva PN; Georgieva SI; Tchekalarova J; Vitkova V; Antonova K; Georgiev A
    Amino Acids; 2019 Mar; 51(3):549-563. PubMed ID: 30604096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new class of highly potent and selective endomorphin-1 analogues containing α-methylene-β-aminopropanoic acids (map).
    Wang Y; Xing Y; Liu X; Ji H; Kai M; Chen Z; Yu J; Zhao D; Ren H; Wang R
    J Med Chem; 2012 Jul; 55(13):6224-36. PubMed ID: 22724433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive effects of spinally administered nociceptin/orphanin FQ and its N-terminal fragments on capsaicin-induced nociception.
    Katsuyama S; Mizoguchi H; Komatsu T; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
    Peptides; 2011 Jul; 32(7):1530-5. PubMed ID: 21672568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family of hemorphins: co-relations between amino acid sequences and effects in cell cultures.
    Blishchenko EY; Sazonova OV; Kalinina OA; Yatskin ON; Philippova MM; Surovoy AY; Karelin AA; Ivanov VT
    Peptides; 2002 May; 23(5):903-10. PubMed ID: 12084521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase.
    Lee J; Mustafa T; McDowall SG; Mendelsohn FA; Brennan M; Lew RA; Albiston AL; Chai SY
    J Pharmacol Exp Ther; 2003 Apr; 305(1):205-11. PubMed ID: 12649370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.